We don't know whether the most recent response to this request contains information or not – if you are Caroline Lee please sign in and let everyone know.

UAEM - Licensing and patenting practices of COVID-19 technologies

We're waiting for Caroline Lee to read a recent response and update the status.

Dear Durham University,

For the purpose of clarity, please adhere to the following definitions when answering these questions:
Definitions
Low and middle income country: A country that is defined as ‘low’, ‘lower-middle’ and ‘upper-middle’ income by the World Bank for the year 2018. Income status defined by GNI per capita.
Source: World bank, available online [https://tinyurl.com/y5dwc2qv]
A patent grants an inventor the exclusive rights to his or her invention. A patent holder can stop other people from selling, manufacturing, producing, or using the invention for a certain period of time.
Source: Upcouncil, available online [https://www.upcounsel.com/what-is-a-pate...
Licence: Permission for the licensee to use the intellectual property rights
Source: TaylorWessing, available online [https://www.taylorwessing.com/download/a...
Exclusive Licence: A licence that allows only the named licensee to exploit the relevant IP rights, the licensor is also excluded from exploiting these IP rights.
Non-Exclusive Licence: A licence that grants any number of licensees to exploit the IP.
Source: TaylorWessing, available online [https://www.taylorwessing.com/synapse/co...
Health Technology: ‘Health technology as defined by the WHO: “A health technology is the application of organized knowledge and skills in the form of devices, medicines, vaccines, procedures and systems developed to solve a health problem and improve quality of lives.’
Source: WHO, available online [https://www.who.int/health-technology-as...
START FOI request:
Q1. Can you release your internal strategy regarding licensing and patenting of COVID-19 related health technologies?
Q2. Does the institution have a formal policy on licensing and patenting of COVID-19 related technologies? If yes, please provide a link or PDF to the relevant policy document.
Q3. Has the university considered updating their strategy regarding the licensing and patenting of health technologies since the start of the pandemic?
Q4. Please provide an Excel spreadsheet with headings as displayed below with all the COVID-19 related health technologies LICENSED by the university AND specify which countries they were licensed in AND specify whether they are exclusive or non-exclusive licenses.
Health Technology Licensed | Country of Licensing | Type of License (Exclusive or Non-Exclusive)
Q5. Please provide a list of patents granted to your organization for any COVID-19 related health technologies listed by patent family, indicating countries/regions in which the patent has been granted.

Q6. Does the institution have any plans on signing up to the Open-COVID pledge (https://opencovidpledge.org/) or any similar initiative that seeks to minimise intellectual property rights barriers during the COVID-19 pandemic? If yes, please specify.

Q7. Is the institution considering the licensing of COVID-19 related health technologies to the Covid Technology Access Pool (C-TAP) or the Medicines Patent Pool (MPP) during the pandemic? If yes, please specify.

END FOI request.
If you have any questions please do not hesitate to contact me by email.

Yours faithfully,
Caroline Lee

ACCESS I., Durham University

Dear Caroline Lee,

Freedom of Information Request

I acknowledge receipt of your email below requesting information from Durham University.

Please be advised that the University will respond as soon as possible and in any event within 20 working days.

The University, like other organisations, is facing unprecedented challenges during the coronavirus (COVID-19) pandemic. Please be advised that there may be a delay in our full response to you; we will let you know if this will be the case.

Yours sincerely

Information Governance Unit
Durham University

Information Governance Unit, University Secretary’s Office
t: +44 (0) 191 334 6103/46246 e: [Durham University request email]

PRIVACY NOTICE: The information in this e-mail and any attachments is confidential. It is intended solely for the addressee or addressees. If you are not the intended recipient please delete the message and any attachments and notify the sender of misdelivery. Any use or disclosure of the contents of either is unauthorised and may be unlawful. This e-mail has been created in the knowledge that Internet e-mail is not a 100% secure communications medium. We advise that you understand and observe this lack of security when e-mailing us. Although steps have been taken to ensure that this e-mail and any attachments are free from any virus, we advise that in keeping with good computing practice the recipient should ensure they are actually virus free. All liability for viruses is excluded to the fullest extent permitted by law.

show quoted sections

ACCESS I., Durham University

Dear Caroline Lee

 

Thank you for your request for information from Durham University. 
Colleagues have provided the information below in response to your
questions.

 

Q1. Can you release your internal strategy regarding licensing and
patenting of COVID-19 related health technologies?

Information not held.

 

Q2. Does the institution have a formal policy on licensing and patenting
of COVID-19 related technologies?  If yes, please provide a link or PDF to
the relevant policy document.

Information not held.

 

Q3. Has the university considered updating their strategy regarding the
licensing and patenting of health technologies since the start of the
pandemic?

Information not held.

 

Q4. Please provide an Excel spreadsheet with headings as displayed below
with all the COVID-19 related health technologies LICENSED by the
university AND specify which countries they were licensed in AND specify
whether they are exclusive or non-exclusive licenses.

Health Technology Licensed | Country of Licensing | Type of License
(Exclusive or Non-Exclusive)

Information not held.

 

Q5. Please provide a list of patents granted to your organization for any
COVID-19 related health technologies listed by patent family, indicating
countries/regions in which the patent has been granted.

Information not held.

 

Q6. Does the institution have any plans on signing up to the Open-COVID
pledge ([1]https://opencovidpledge.org/) or any similar initiative that
seeks to minimise intellectual property rights barriers during the
COVID-19 pandemic? If yes, please specify.

Information not held.

 

Q7. Is the institution considering the licensing of COVID-19 related
health technologies to the Covid Technology Access Pool (C-TAP) or the
Medicines Patent Pool (MPP) during the pandemic? If yes, please specify.

Information not held.

 

If you are dissatisfied with the University’s response to your freedom of
information request, you can ask us to internally review our handling of
your request, including the application of any exemptions applied.  To do
this, please email [2][Durham University request email] or write to:

 

Information Governance Unit

The Palatine Centre

Stockton Road

Durham

DH1 3LE          

 

Please state the grounds on which you wish the decision to be reviewed and
enclose any other information that may be useful in considering the matter
further.  We aim to inform you of our decision within 20 working days from
the date your request for internal review is received.

 

If you are not satisfied with the results of the internal review you may
apply to the Information Commissioner's Office for an independent review.

 

Information Commissioner's Office

Wycliffe House

Water Lane                                                  

Wilmslow

Cheshire

SK9 5AF

[3]www.ico.org.uk

 

Yours sincerely

 

Information Governance Unit

Durham University

--------------------------------------------------------------------------

Information Governance Unit, University Secretary’s Office

e: [4][Durham University request email]

show quoted sections

We don't know whether the most recent response to this request contains information or not – if you are Caroline Lee please sign in and let everyone know.